COLUMBUS, Ohio--(BUSINESS WIRE)--DNA Nanobots, a biotechnology leader in DNA nanoparticles engineered for targeted therapeutics, announced today that Dr. John C. Byrd, M.D., has joined its scientific ...

Platform company uses antibody-targeted DNA nanoparticles to deliver a wide range of therapeutic payloads to desired tissue. “Most therapeutics fail in clinical trials,” said CEO and co-founder Jeff ...

DNA Nanobots, a pioneer in self-assembling nanoscale therapeutics, today announced it has secured $3.5 million in funding from a prominent, family office. This significant investment solidifies the ...

IT’S a computer – inside a cockroach. Nanoscale entities made of DNA that can perform the same logic operations as a silicon-based computer have been introduced into a living animal. “They could ...